BNP PARIBAS FINANCIAL MARKETS - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 44 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$197
-99.8%
232
+134.3%
0.00%
Q3 2022$81,000
-93.3%
99
-91.9%
0.00%
Q2 2022$1,212,000
+8557.1%
1,224
+30500.0%
0.00%
Q4 2020$14,000
-12.5%
40.0%0.00%
Q3 2020$16,000
+45.5%
40.0%0.00%
Q2 2020$11,000
-93.4%
4
-94.9%
0.00%
Q1 2020$167,000
-61.2%
790.0%0.00%
Q4 2019$430,000
-92.1%
79
-95.6%
0.00%
Q3 2019$5,436,000
-19.5%
1,8060.0%0.00%
Q2 2019$6,754,000
-46.5%
1,806
-42.5%
0.00%
Q1 2019$12,635,000
+1547.3%
3,143
+1403.8%
0.00%
Q4 2018$767,000
-78.6%
209
-50.0%
0.00%
Q3 2018$3,586,000
-32.5%
418
-13.6%
0.00%
Q2 2018$5,314,000
-73.0%
484
-71.7%
0.00%
Q1 2018$19,705,000
+12.1%
1,709
+0.8%
0.00%
Q4 2017$17,571,000
+93.4%
1,696
+197.5%
0.00%
Q3 2017$9,086,000
+97.6%
570
+50.0%
0.00%
Q2 2017$4,598,000
+3578.4%
380
+6233.3%
0.00%
Q1 2017$125,000
-79.7%
6
-86.0%
0.00%
Q4 2016$615,000
-83.4%
43
-80.9%
0.00%
Q3 2016$3,701,000
+98.1%
225
+71.8%
0.00%
Q2 2016$1,868,0001310.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,749,379$18,147,0003.77%
VR Adviser, LLC 3,427,461$16,589,0002.13%
ADAMS STREET PARTNERS LLC 3,275,616$15,854,0002.04%
Telemetry Investments, L.L.C. 196,168$949,0001.28%
DC Investments Management, LLC 50,709$245,0000.46%
Orbimed Advisors 6,943,654$33,607,0000.37%
EcoR1 Capital, LLC 2,081,077$10,072,0000.35%
BVF INC/IL 1,370,947$6,635,0000.26%
Ikarian Capital, LLC 757,545$3,666,0000.26%
CHI Advisors LLC 165,927$803,0000.23%
View complete list of CORVUS PHARMACEUTICALS INC shareholders